At a glance
ClinicalIndex Comparison RecordN/ACompleted· 102 enrolled
Drug / intervention
EMBOVAC Aspiration Catheterdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Prospective Evaluation to Characterize the Real-World Performance of the EMBOVAC Aspiration Catheter for Neurothrombectomy: A Post-Market Clinical Follow-up Trial.
Cerenovus, Part of DePuy Synthes Products, Inc.·observational·Posted Aug 31, 2020·Updated Jan 26, 2024
In Brief
An observational study evaluating EMBOVAC Aspiration Catheter for Acute Ischemic Stroke. Completed, enrolled 102 participants across 2 sites in 2 countries.
Detailed Summary
A post-market study evaluating the EMBOVAC Aspiration Catheter in acute ischemic stroke patients with confirmed intracranial large vessel occlusion.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsAcute Ischemic Stroke
CountriesGermany, United Kingdom
Collaborators--
Timeline
N/ACompletedFinished
202120222023202420252026
First PostedAug 2020
Enrollment StartOct 2020
Primary CompletionMay 2022
Study CompletionJul 2022
TodayJul 2026
First PostedAug 31, 2020
Enrollment StartOct 15, 2020
Primary CompletionMay 2, 2022
Study CompletionJul 26, 2022
TodayJul 2, 2026
Enrollment to primary: 1.5 yearsPosted 5.8 years ago
Interventions
EMBOVAC Aspiration Catheterdevice
The EMBOVAC Aspiration catheter is used to treat acute ischemic stroke. The catheter can be used to facilitate introduction of diagnostic or therapeutic agents and is also intended for use in removal/aspiration of emboli and thrombi from selected blood vessels in the neuro vasculature.